Cargando…

ADAR1 overexpression is associated with cervical cancer progression and angiogenesis

BACKGROUND: This study aimed to assess the role of RNA-dependent adenosine deaminase (ADAR1) in cervical squamous cell carcinoma occurrence and progression. METHODS: ADAR1 expression levels in stage IA and stage IIA cervical squamous cell carcinoma (group A), cervical intraepithelial neoplasia (CIN)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ying, Wang, He, Lin, Wenyi, Shuai, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5251241/ https://www.ncbi.nlm.nih.gov/pubmed/28109322 http://dx.doi.org/10.1186/s13000-017-0600-0

Ejemplares similares

Overexpression of Notch1 is associated with the progression of cervical cancer
por: Sun, Yan, et al.
Publicado: (2021)

Aberrant overexpression of ADAR1 promotes gastric cancer progression by activating mTOR/p70S6K signaling
por: Dou, Ning, et al.
Publicado: (2016)

ADAR1 has an oncogenic function and can be a prognostic factor in cervical cancer
por: Nakamura, Keiichiro, et al.
Publicado: (2023)

Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis
por: Anadón, C, et al.
Publicado: (2016)

The ADAR1 editome reveals drivers of editing-specificity for ADAR1-isoforms
por: Kleinova, Renata, et al.
Publicado: (2023)

Targeting ADAR1 suppresses progression and peritoneal metastasis of gastric cancer through Wnt / β-catenin pathway
por: Li, Zhiyong, et al.
Publicado: (2021)

Erratum: Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis
por: Anadón, C, et al.
Publicado: (2016)

ADAR1 Editing and its Role in Cancer
por: Xu, Li-Di, et al.
Publicado: (2018)

Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer
por: Okugawa, Yoshinaga, et al.
Publicado: (2018)

RSF-1 overexpression determines cancer progression and drug resistance in cervical cancer
por: Wang, Xiangyu, et al.
Publicado: (2018)

The ADAR protein family
por: Savva, Yiannis A, et al.
Publicado: (2012)

ADAR1-Mediated RNA Editing and Its Role in Cancer
por: Liu, Jizhe, et al.
Publicado: (2022)

Upregulation of ADAR Promotes Breast Cancer Progression and Serves as a Potential Therapeutic Target
por: Li, Xiao, et al.
Publicado: (2021)

ADAR1 restricts LINE-1 retrotransposition
por: Orecchini, Elisa, et al.
Publicado: (2017)

ADAR1 is essential for intestinal homeostasis and stem cell maintenance
por: Qiu, W, et al.
Publicado: (2013)

Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma
por: WANG, WEI, et al.
Publicado: (2013)

Functional conservation in human and Drosophila of Metazoan ADAR2 involved in RNA editing: loss of ADAR1 in insects
por: Keegan, Liam P., et al.
Publicado: (2011)

Optimal guideRNAs for re-directing deaminase activity of hADAR1 and hADAR2 in trans
por: Schneider, Marius F., et al.
Publicado: (2014)

ADAR1 and MicroRNA; A Hidden Crosstalk in Cancer
por: Cho, Charles J., et al.
Publicado: (2017)

Genetically modified endothelial progenitor cells with hNotch1.ICN overexpression display facilitated angiogenesis
por: Guo, Peng, et al.
Publicado: (2020)

ADAR1-mediated regulation of melanoma invasion
por: Nemlich, Yael, et al.
Publicado: (2018)

RNA Editing, ADAR1, and the Innate Immune Response
por: Wang, Qingde, et al.
Publicado: (2017)

ADAR1 Alleviates Inflammation in a Murine Sepsis Model via the ADAR1-miR-30a-SOCS3 Axis
por: Shangxun, Zhou, et al.
Publicado: (2020)

Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer
por: Zhou, Xiang, et al.
Publicado: (2015)

ADARs act as potent regulators of circular transcriptome in cancer
por: Shen, Haoqing, et al.
Publicado: (2022)

Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers
por: Lee, K T, et al.
Publicado: (2004)

Overexpression of SCYL1 Is Associated with Progression of Breast Cancer
por: Sun, Aiqin, et al.
Publicado: (2022)

ADAR1 affects gastric cancer cell metastasis and reverses cisplatin resistance through AZIN1
por: Wang, Honghong, et al.
Publicado: (2023)

ADAR1-mediated RNA-editing of 3′UTRs in breast cancer
por: Sagredo, Eduardo A., et al.
Publicado: (2018)

URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancer
por: Zhang, Lan, et al.
Publicado: (2014)

Five novel mutations in the ADAR1 gene associated with dyschromatosis symmetrica hereditaria
por: Liu, Qi, et al.
Publicado: (2014)

ADAR1- and ADAR2-mediated regulation of maturation and targeting of miR-376b to modulate GABA neurotransmitter catabolism
por: Widmark, Albin, et al.
Publicado: (2022)

ADAR1 links R-loop homeostasis to ATR activation in replication stress response
por: Zhang, Biao, et al.
Publicado: (2023)

ADAR1: “Editor-in-Chief” of Cytoplasmic Innate Immunity
por: Lamers, Mart M., et al.
Publicado: (2019)

ADAR1: a mast regulator of aging and immunity
por: Zhang, Yigan, et al.
Publicado: (2023)

ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma
por: Yang, Wendi, et al.
Publicado: (2023)

Promoting RNA editing by ADAR attraction
por: Danan-Gotthold, Miri, et al.
Publicado: (2017)

ADAR RNA editing below the backbone
por: Keegan, Liam, et al.
Publicado: (2017)

Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization
por: Zhang, Qi, et al.
Publicado: (2022)

Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells
por: Gannon, Hugh S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s14dfgkcvo2nlot3ngnnv1bcim